ZGN:NYSEErmenegildo Zegna N.V. Analysis
Data as of 2026-05-28 - not real-time
$14.41
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Ermenegildo Zegna (ZGN) is trading at $14.41, well above its 30‑day DCF fair value of $9.68 and the 20‑day SMA of $12.77, indicating a price premium despite a modest revenue growth of 0.3%. Technicals remain bullish – the MACD line sits above its signal (0.55 vs 0.45) and the price is above both the 20‑day and 50‑day SMAs, though the RSI of 73 flags an overbought condition. The stock benefits from a recent analyst upgrade to **Buy** by TD Cowen and a raised target by BofA, supported by a solid Q1 sales beat (+7% YoY) driven by Zegna and Tom Ford brands, with China returning to growth.
Fundamentally, ZGN posts strong gross margins (67.5%) and healthy operating cash flow, while maintaining a modest dividend yield of 0.98% with a 31.6% payout ratio, suggesting dividend sustainability. However, the balance sheet shows a high debt‑to‑equity of 89% and a beta of ~1.5, contributing to elevated volatility (≈46% 30‑day) and sector‑specific cyclicality risks. The combination of an overvalued market price, high volatility, and significant debt tempers enthusiasm, positioning the stock as a **hold** in the short term but a **buy** for investors comfortable with medium‑term upside from brand momentum and strategic growth in key markets.
Fundamentally, ZGN posts strong gross margins (67.5%) and healthy operating cash flow, while maintaining a modest dividend yield of 0.98% with a 31.6% payout ratio, suggesting dividend sustainability. However, the balance sheet shows a high debt‑to‑equity of 89% and a beta of ~1.5, contributing to elevated volatility (≈46% 30‑day) and sector‑specific cyclicality risks. The combination of an overvalued market price, high volatility, and significant debt tempers enthusiasm, positioning the stock as a **hold** in the short term but a **buy** for investors comfortable with medium‑term upside from brand momentum and strategic growth in key markets.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above fair value and overbought RSI
- Bullish MACD but decreasing volume trend
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst upgrades and raised price targets
- Strong brand execution with Zegna and Tom Ford driving sales
- Improving demand in China and robust gross margins
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustainable dividend supported by cash flow
- Elevated debt levels and beta indicating higher systematic risk
- Long‑term brand equity and diversification across luxury segments
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin5.14%
P/E Ratio32.8
ROE10.52%
ROA3.59%
Debt/Equity89.38
P/B Ratio3.2
Op. Cash Flow$335.6M
Free Cash Flow$246.6M
Technical Analysis
TrendBullish
RSI73.3
Support$11.41
Resistance$14.45
MA 20$12.77
MA 50$11.66
MA 200$10.36
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34
Valuation
Fair Value$9.68
Target Price$13.33
Upside/Downside-7.48%
GradeOvervalued
TypeBlend
Dividend Yield0.98%
Risk Assessment
Beta1.53
Volatility46.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.